About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 462 randomised Chinese adults with obesity (BMI 30 or higher), with or without type 2 diabetes
- Sample size
- 462
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Chinese population only; mean age about 34. The Europe PMC record gives no funding statement, but several authors are affiliated with Innovent Biologics. Abstract read via Europe PMC; full text not read. The published title names the studied dose; it is left out here.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.